Brain training targets impulse control to fight OCD and related disorders

NCT ID NCT05377125

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests whether a computerized training program designed to improve response inhibition — the ability to stop an automatic action — can reduce symptoms in people with obsessive-compulsive disorder, trichotillomania (hair-pulling), or skin-picking disorder. Participants are randomly assigned to receive either the active training or a placebo version over 8 to 16 sessions. The researchers measure changes in symptom severity and brain activity using MRI scans to see if the training works and how.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
computerized cognitive training
What this could lead to
If effective, this training could offer a new, non-drug treatment option for people with obsessive-compulsive and related disorders.
What could go wrong
This is an early-stage trial with a modest number of participants. The training may not produce lasting symptom improvement, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSESSIVE - COMPULSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UWM Anxiety Disorders Laboratory

    RECRUITING

    Milwaukee, Wisconsin, 53211, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.